Wanian M Alwanian, Angela L Tyner: Protein tyrosine kinase 6 signaling in prostate cancer. Am J Clin Exp Urol 2020;8(1):1-8. (Full text, PDF)
Feng Li, Laura E Pascal, Ke Wang, Yibin Zhou, Goundappa K Balasubramani, Katherine J O’Malley, Rajiv Dhir, Kai He, Donna Stolz, Donald B DeFranco, Naoki Yoshimura, Joel B Nelson, Tie Chong, Peng Guo, Dalin He, Zhou Wang: Transforming growth factor beta 1 impairs benign prostatic luminal epithelial cell monolayer barrier function. Am J Clin Exp Urol 2020;8(1):9-17. (Full text, PDF)
Laura E Pascal, Lora H Rigatti, Junkui Ai, Aiyuan Zhang, Jianhua Zhou, Joel B Nelson, Zhou Wang: EAF2 loss induces prostatic intraepithelial neoplasia from luminal epithelial cells in mice. Am J Clin Exp Urol 2020;8(1):18-27. (Full text, PDF)
Brady L Miller, E Jason Abel, Glenn Allen, Jessica R Schumacher, David Jarrard, Tracy Downs, Kyle A Richards: Trends in epidural anesthesia use at the time of radical cystectomy and its association with perioperative and survival outcomes: a population-based analysis. Am J Clin Exp Urol 2020;8(1):28-37. (Full text, PDF)
Hadi Maleki, Reza Shahriar, Reza Kazemi, Farinaz Khodadadi: Frequencies of accessory renal arteries in 129 Iranian patients. Am J Clin Exp Urol 2020;8(1):38-42. (Full text, PDF)
Mozhde Askari, Amid Yazdani, Mohammad Yazdani, Mohammad Hossein Izadpanahi: Serum levels of total and urine level of PCA3 in patients with benign prostatic hyperplasia and prostate cancer. Am J Clin Exp Urol 2020;8(1):43-47. (Full text, PDF)
Thomas R Nirschl, Margueritta El Asmar, Wesley W Ludwig, Sudipto Ganguly, Michael A Gorin, Michael H Johnson, Phillip M Pierorazio, Charles G Drake, Mohamad E Allaf, Jelani C Zarif: Transcriptional profiling of tumor associated macrophages in human renal cell carcinoma reveals significant heterogeneity and opportunity for immunomodulation. Am J Clin Exp Urol 2020;8(1):48-58. (Full text, PDF)
Anne E Turco, Samuel Thomas, LaTasha K Crawford, Weiping Tang, Richard E Peterson, Lingjun Li, William A Ricke, Chad M Vezina: In utero and lactational 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure exacerbates urinary dysfunction in hormone-treated C57BL/6J mice through a non-malignant mechanism involving proteomic changes in the prostate that differ from those elicited by testosterone and estradiol. Am J Clin Exp Urol 2020;8(1):59-72. (Full text, PDF, Supplementary Table 3)
